Title:
DUAL FUNCTION PROTEINS AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
Document Type and Number:
WIPO Patent Application WO/2017/074123
Kind Code:
A1
Abstract:
The present invention provides a dual function protein prepared by linking a biologically active protein and an FGF mutant protein to an Fc region of an immunoglobulin, which has improved pharmacological efficacy, in vivo duration and protein stability. A dual function protein according to the present invention exhibits improved pharmacological efficacy, in vivo duration and protein stability, and a pharmaceutical composition containing the dual function protein as an active ingredient may be effectively used as a therapeutic agent for diabetes, obesity, dyslipidemia, metabolic syndrome, non-alcoholic fatty liver diseases, non-alcoholic steatohepatitis or cardiovascular diseases.
Inventors:
KIM JUN HWAN (KR)
LIM SEYOUNG (KR)
SEO MINJI (KR)
CHOI HYUN HO (KR)
KIM DOHOON (KR)
JU MI KYEONG (KR)
PARK JU-YOUNG (KR)
KIM SEUL GI (KR)
LIM SANGMYOUN (KR)
KIM JONG GYUN (KR)
NAM SU YOUN (KR)
LIM SEYOUNG (KR)
SEO MINJI (KR)
CHOI HYUN HO (KR)
KIM DOHOON (KR)
JU MI KYEONG (KR)
PARK JU-YOUNG (KR)
KIM SEUL GI (KR)
LIM SANGMYOUN (KR)
KIM JONG GYUN (KR)
NAM SU YOUN (KR)
Application Number:
PCT/KR2016/012300
Publication Date:
May 04, 2017
Filing Date:
October 28, 2016
Export Citation:
Assignee:
YUHAN CORP (KR)
International Classes:
C07K14/50; A61K38/17; A61K38/18; A61K38/26; C07K14/46; C07K14/605; C07K19/00
Domestic Patent References:
WO2009020802A2 | 2009-02-12 |
Foreign References:
US20140243503A1 | 2014-08-28 | |||
US20120238496A1 | 2012-09-20 | |||
US20130129724A1 | 2013-05-23 | |||
US20120172298A1 | 2012-07-05 |
Other References:
See also references of EP 3368555A4
Attorney, Agent or Firm:
FIRSTLAW P.C. (KR)
Download PDF:
Previous Patent: HEIGHT-ADJUSTABLE BED
Next Patent: CONDUCTIVE MATERIAL DISPERSED LIQUID AND LITHIUM SECONDARY BATTERY MANUFACTURED USING SAME
Next Patent: CONDUCTIVE MATERIAL DISPERSED LIQUID AND LITHIUM SECONDARY BATTERY MANUFACTURED USING SAME